ORIGINAL RESEARCH
Published on 30 May 2025
Real-world analysis of immunochemotherapy in recurrent small-cell lung cancer: opportunities for second-line approaches
doi 10.3389/fphar.2025.1591643
- 290 views
- Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- Combination Therapies in Cancer Treatment: Enhancing Efficacy and Reducing Resistance
Combination Therapies in Cancer Treatment: Enhancing Efficacy and Reducing Resistance
4,651
Total downloads
19k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
MINI REVIEW
Accepted on 23 May 2025
Chemotherapy-Induced Immunogenic Cell Death in Combination with ICIs: A Brief Review of Mechanisms, Clinical Insights, and Therapeutic Implications
doi 10.3389/fphar.2025.1572195
ORIGINAL RESEARCH
Published on 19 May 2025
Iodine-131 induces ferroptosis and synergizes with sulfasalazine in differentiated thyroid cancer cells via suppressing SLC7A11
doi 10.3389/fonc.2025.1580828
- 361 views
CLINICAL TRIAL
Accepted on 12 May 2025
Clinical Outcomes of DNA-damaging agents (DDAs) and DNA damage response inhibitors (DDRis) Combinations in Cancer: A Data-Driven Review
doi 10.3389/fonc.2025.1577468
- 159 views
REVIEW
Published on 30 Apr 2025
Nanotechnology-driven strategies in postoperative cancer treatment: innovations in drug delivery systems
doi 10.3389/fphar.2025.1586948
- 557 views
ORIGINAL RESEARCH
Published on 17 Apr 2025
Targeting PCNA/PARP1 axis inhibits the malignant progression of hepatocellular carcinoma
doi 10.3389/fphar.2025.1571786
- 698 views
ORIGINAL RESEARCH
Published on 27 Mar 2025
Enhancing survival outcomes in unresectable hepatocellular carcinoma: a prospective cohort study on the effects of Huaier granules with targeted therapy plus immunotherapy
doi 10.3389/fphar.2025.1529010
- 646 views
ORIGINAL RESEARCH
Published on 25 Mar 2025
Milciclib-mediated CDK2 inhibition to boost radiotherapy sensitivity in colorectal cancer
doi 10.3389/fphar.2025.1557925
- 779 views
ORIGINAL RESEARCH
Published on 24 Mar 2025
Efficacy and safety of PD-1/PD-L1 inhibitors combined with tyrosine kinase inhibitors as first-line treatment for hepatocellular carcinoma: a meta-analysis and trial sequential analysis of randomized controlled trials
doi 10.3389/fphar.2025.1535444
- 896 views
REVIEW
Published on 10 Mar 2025
TCR-T cell therapy for solid tumors: challenges and emerging solutions
doi 10.3389/fphar.2025.1493346
- 1,949 views
- 1 citation
MINI REVIEW
Published on 21 Feb 2025
Antibody-drug conjugate combinations in cancer treatment: clinical efficacy and clinical study perspectives
doi 10.3389/fphar.2025.1556245
- 2,234 views
- 1 citation
SYSTEMATIC REVIEW
Published on 06 Dec 2024
Efficacy and safety of TACE combined with traditional Chinese medicine versus TACE alone in hepatocellular carcinoma: bayesian network meta-analysis and pharmacological mechanisms study
doi 10.3389/fphar.2024.1495343
- 1,334 views
Published in
Frontiers in Pharmacology
Pharmacology of Anti-Cancer Drugs
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: